Study Details

General Information

Covance OA Knee

A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Dose-Ranging Study to Evaluate the Efficacy, Safety and Tolerability of XXXXXX versus Placebo in Patients with Osteoarthritis (OA) of the Knee

Protocol
Identifier
UID7f99e3d6-afce-4947-bbfa-85584f46e787
StatusNot Selected
Phase2
CategoryOsteoarthritis/Knee
Launch Year0
NCT Number-
Created2013-09-10 17:00
Last Updated2013-09-10 17:00

Description

No description provided.

Comment

No comment.

Target Dates

NameDateRequired
Enrollment ClosedNo
Enrollment OpenNo
First Patient First VisitNo
Site Initiation Mtg.No
PI Meeting StartNo
PI Meeting EndNo
PI Meeting ArrivalNo
PI Meeting DepartureNo
Closeout DateNo
Final PatientVisitNo
PreStudy Selection VisitNo
Target Date 12No
Target Date 13No
Target Date 14No

Leadership

RoleStaffLoginRequired
PrincipalMartinez, GilbertGJMartinezNo
Recruiter-No
CoordinatorPereira, CynthiaCPereiraNo
RegulatoryAguirre, SandraSAguirreNo

Custom Fields

No custom fields.

Sponsor & Organization

SponsorUnknown
DivisionUnknown
TeamUnknown
Managing SiteCatalina Research Institute, LLC
Organization

Contacts

IRB Ref
CROCovance -LabCorp Drug Development
CRO Ref
Correspondence0

Opportunity

Probability0
Comment
Status ColorLightgray
Currency-
Mayra Sibley

2 Hours

Hi there, I'm Jesse and you?
You

3 minutes

My name is Anne Clarc.
Mayra Sibley

40 seconds

Nice to meet you Anne.
How can i help you?